Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinming Yu

Showing results (691-700 of 779) with videos related to

Pageof 78
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagusXiaojun Zhong, Jinming Yu, Baijiang Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Can an ¹⁸F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?Hui Zhang, Ning Liu, Song Gao, et al.
BMC Cancer|July 30, 2024
Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progressionPeng Sun, Zhenfeng Li, Zaojun Yan, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profilingXinyi Huang, Baoqing Tian, Ziyuan Ren, et al.
Oncotargets and Therapy|July 13, 2018
A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancerHeming Lu, Yuying Wu, Xu Liu, et al.
Cell Reports|August 13, 2025
Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acidQian Song, Xinpei Li, Qing Li, et al.
Radiation Oncology (London, England)|June 8, 2021
Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imagingShulun Nie, Yufang Zhu, Jia Yang, et al.
Clinical Lung Cancer|July 14, 2019
Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung CancerDong Guo, Feng Jin, Wang Jing, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 16, 2025
Integration of Circulating Tumor DNA and Metabolic Parameters on <sup>18</sup>F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung CancerLeilei Wu, Zhenshan Zhang, Chenxue Jiang, et al.
Therapeutic Advances in Medical Oncology|April 24, 2026
Role of radiotherapy in the treatment of <i>EGFR</i>-mutant non-small-cell lung cancer: a narrative reviewQian Wang, Fengxin Sun, Meng Wu, et al.
Pageof 78

Showing results (691-700 of 779) with videos related to

Sort By:
Pageof 78
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagusXiaojun Zhong, Jinming Yu, Baijiang Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Can an ¹⁸F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?Hui Zhang, Ning Liu, Song Gao, et al.
BMC Cancer|July 30, 2024
Lenvatinib targets STAT-1 to enhance the M1 polarization of TAMs during hepatocellular carcinoma progressionPeng Sun, Zhenfeng Li, Zaojun Yan, et al.
Therapeutic Advances in Medical Oncology|October 21, 2024
CD34 as a potential prognostic indicator for camrelizumab response in advanced non-small-cell lung cancer: insights from digital spatial profilingXinyi Huang, Baoqing Tian, Ziyuan Ren, et al.
Oncotargets and Therapy|July 13, 2018
A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancerHeming Lu, Yuying Wu, Xu Liu, et al.
Cell Reports|August 13, 2025
Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acidQian Song, Xinpei Li, Qing Li, et al.
Radiation Oncology (London, England)|June 8, 2021
Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imagingShulun Nie, Yufang Zhu, Jia Yang, et al.
Clinical Lung Cancer|July 14, 2019
Incorporation of the SUVmax Measured From FDG PET and Neutrophil-to-lymphocyte Ratio Improves Prediction of Clinical Outcomes in Patients With Locally Advanced Non-small-cell Lung CancerDong Guo, Feng Jin, Wang Jing, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 16, 2025
Integration of Circulating Tumor DNA and Metabolic Parameters on <sup>18</sup>F-Fludeoxyglucose Positron Emission Tomography for Outcome Prediction in Unresectable Locally Advanced Non-Small Cell Lung CancerLeilei Wu, Zhenshan Zhang, Chenxue Jiang, et al.
Therapeutic Advances in Medical Oncology|April 24, 2026
Role of radiotherapy in the treatment of <i>EGFR</i>-mutant non-small-cell lung cancer: a narrative reviewQian Wang, Fengxin Sun, Meng Wu, et al.
Pageof 78